A detailed history of Huntington National Bank transactions in Baxter International Inc stock. As of the latest transaction made, Huntington National Bank holds 27,036 shares of BAX stock, worth $797,562. This represents 0.01% of its overall portfolio holdings.

Number of Shares
27,036
Previous 30,942 12.62%
Holding current value
$797,562
Previous $1.04 Million 0.87%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$32.85 - $40.26 $128,312 - $157,255
-3,906 Reduced 12.62%
27,036 $1.03 Million
Q2 2024

Aug 08, 2024

SELL
$32.87 - $43.55 $96,046 - $127,253
-2,922 Reduced 8.63%
30,942 $1.04 Million
Q1 2024

May 03, 2024

SELL
$37.88 - $43.77 $96,707 - $111,744
-2,553 Reduced 7.01%
33,864 $1.45 Million
Q4 2023

Feb 07, 2024

SELL
$31.71 - $38.95 $194,794 - $239,269
-6,143 Reduced 14.43%
36,417 $1.41 Million
Q3 2023

Nov 08, 2023

SELL
$37.32 - $49.29 $330,020 - $435,871
-8,843 Reduced 17.2%
42,560 $1.61 Million
Q2 2023

Aug 11, 2023

SELL
$39.98 - $47.68 $2.07 Million - $2.47 Million
-51,699 Reduced 50.14%
51,403 $2.34 Million
Q1 2023

May 10, 2023

SELL
$37.58 - $52.57 $966,745 - $1.35 Million
-25,725 Reduced 19.97%
103,102 $4.18 Million
Q4 2022

Feb 09, 2023

SELL
$49.7 - $57.71 $1.08 Million - $1.25 Million
-21,729 Reduced 14.43%
128,827 $6.57 Million
Q3 2022

Nov 07, 2022

SELL
$53.86 - $66.8 $1.54 Million - $1.9 Million
-28,512 Reduced 15.92%
150,556 $8.11 Million
Q2 2022

Aug 09, 2022

SELL
$63.83 - $80.0 $1.93 Million - $2.42 Million
-30,208 Reduced 14.43%
179,068 $11.5 Million
Q1 2022

May 10, 2022

SELL
$76.85 - $89.45 $3.03 Million - $3.53 Million
-39,477 Reduced 15.87%
209,276 $16.2 Million
Q4 2021

Jan 21, 2022

SELL
$74.57 - $87.19 $10.6 Million - $12.3 Million
-141,633 Reduced 36.28%
248,753 $21.4 Million
Q3 2021

Oct 28, 2021

SELL
$73.77 - $83.61 $15.9 Million - $18 Million
-215,363 Reduced 35.55%
390,386 $31.4 Million
Q2 2021

Jul 30, 2021

BUY
$80.5 - $88.01 $1.52 Million - $1.66 Million
18,840 Added 3.21%
605,749 $48.8 Million
Q1 2021

Apr 12, 2021

BUY
$76.38 - $86.03 $1.31 Million - $1.47 Million
17,099 Added 3.0%
586,909 $49.5 Million
Q4 2020

Jan 11, 2021

SELL
$75.39 - $82.36 $234,236 - $255,892
-3,107 Reduced 0.54%
569,810 $45.7 Million
Q3 2020

Oct 30, 2020

BUY
$78.33 - $90.73 $301,962 - $349,764
3,855 Added 0.68%
572,917 $46.1 Million
Q2 2020

Jul 30, 2020

BUY
$78.66 - $94.14 $2.58 Million - $3.09 Million
32,826 Added 6.12%
569,062 $49 Million
Q1 2020

Apr 27, 2020

BUY
$71.57 - $93.3 $2.16 Million - $2.82 Million
30,234 Added 5.98%
536,236 $43.5 Million
Q4 2019

Jan 17, 2020

BUY
$76.7 - $88.45 $656,321 - $756,866
8,557 Added 1.72%
506,002 $42.3 Million
Q3 2019

Nov 01, 2019

BUY
$81.4 - $89.78 $301,749 - $332,814
3,707 Added 0.75%
497,445 $43.5 Million
Q2 2019

Jul 23, 2019

BUY
$73.44 - $82.41 $1.12 Million - $1.25 Million
15,209 Added 3.18%
493,738 $40.4 Million
Q1 2019

Apr 09, 2019

BUY
$64.48 - $81.31 $506,296 - $638,446
7,852 Added 1.67%
478,529 $38.9 Million
Q4 2018

Jan 28, 2019

BUY
$61.45 - $77.8 $1.05 Million - $1.33 Million
17,059 Added 3.76%
470,677 $31 Million
Q3 2018

Oct 18, 2018

BUY
$70.71 - $77.75 $1.66 Million - $1.82 Million
23,469 Added 5.46%
453,618 $35 Million
Q2 2018

Jul 19, 2018

BUY
$63.43 - $75.41 $1.96 Million - $2.33 Million
30,889 Added 7.74%
430,149 $31.8 Million
Q1 2018

Apr 30, 2018

BUY
$62.56 - $72.26 $1.07 Million - $1.23 Million
17,059 Added 4.46%
399,260 $26 Million
Q4 2017

Feb 02, 2018

BUY
$61.45 - $66.05 $1.31 Million - $1.41 Million
21,333 Added 5.91%
382,201 $24.7 Million
Q3 2017

Oct 24, 2017

BUY
$59.5 - $64.61 $21.5 Million - $23.3 Million
360,868
360,868 $22.6 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $14.9B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Huntington National Bank Portfolio

Follow Huntington National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.